Sanibel Captiva Trust Company Inc. Has $1.97 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Sanibel Captiva Trust Company Inc. lessened its stake in CVS Health Co. (NYSE:CVS - Free Report) by 35.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,119 shares of the pharmacy operator's stock after selling 16,277 shares during the quarter. Sanibel Captiva Trust Company Inc.'s holdings in CVS Health were worth $1,973,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Whitebox Advisors LLC acquired a new position in shares of CVS Health during the 4th quarter valued at $249,000. B&D White Capital Company LLC acquired a new position in CVS Health during the 4th quarter valued at about $417,000. Fairfax Financial Holdings Ltd. Can acquired a new position in CVS Health during the 4th quarter valued at about $121,742,000. Lazard Asset Management LLC boosted its stake in CVS Health by 7.3% during the 4th quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock valued at $192,617,000 after purchasing an additional 293,406 shares during the period. Finally, Seizert Capital Partners LLC boosted its stake in CVS Health by 22.8% during the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after purchasing an additional 105,708 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Wells Fargo & Company reissued an "overweight" rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Argus set a $77.00 target price on shares of CVS Health in a research note on Tuesday, February 18th. UBS Group upped their price target on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Finally, Royal Bank of Canada upped their price target on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

CVS Health Price Performance

CVS stock traded up $1.07 on Friday, hitting $67.42. 7,560,954 shares of the company's stock traded hands, compared to its average volume of 10,978,755. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The stock has a market cap of $85.29 billion, a price-to-earnings ratio of 18.42, a P/E/G ratio of 0.98 and a beta of 0.56. The stock has a fifty day moving average of $65.15 and a 200-day moving average of $60.15. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the previous year, the business earned $1.31 earnings per share. The firm's revenue was up 7.0% compared to the same quarter last year. On average, analysts forecast that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.95%. CVS Health's dividend payout ratio is currently 63.48%.

Insider Activity

In other news, Director Guy P. Sansone purchased 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director now directly owns 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is owned by company insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.